Skip to main content

Child Mortality

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

March Biosciences
March BiosciencesTX - Houston
1 program
Birth Cohort in Rahimyar Khan, PakistanN/A1 trial
Active Trials
NCT02233127Completed2,271Est. Jul 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
March BiosciencesBirth Cohort in Rahimyar Khan, Pakistan

Clinical Trials (1)

Total enrollment: 2,271 patients across 1 trials

NCT02233127March BiosciencesBirth Cohort in Rahimyar Khan, Pakistan

Birth Cohort in Rahimyar Khan, Pakistan

Start: Oct 2014Est. completion: Jul 20162,271 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.